Company page

Palisade Bio, Inc.

Palisade Bio, Inc. (Ticker: PALI) is a public company based in the United States, with a market capitalization of approximately $342 million. The company focuses on developing innovative therapies to improve patient outcomes. Palisade Bio is committed to advancing its pipeline of products aimed at addressing unmet medical needs.